Your browser doesn't support javascript.
[Differential diagnosis of hydroxychloroquine-induced retinal damage]. / Differentsial'naya diagnostika porazheniya setchatki pri toksicheskom vozdeistvii gidroksikhlorokhina.
Budzinskaya, M V; Durzhinskaya, M H.
  • Budzinskaya MV; Research Institute of Eye Diseases, Moscow, Russia.
  • Durzhinskaya MH; Research Institute of Eye Diseases, Moscow, Russia.
Vestn Oftalmol ; 136(4. Vyp. 2): 265-271, 2020.
Artículo en Ruso | MEDLINE | ID: covidwho-745625
ABSTRACT
Coronavirus infection is currently en extremely relevant scientific topic due to the emergence of a new serotype that causes a condition identified as Severe Acute Respiratory Syndrome (SARS)-COV-2. Chloroquine and hydroxychloroquine have a long history of use against other infectious diseases, they are available and inexpensive, so the possibility of using them in vivo and in vitro to suppress the infectious agent was examined. Despite the noted therapeutic potential of these drugs, it was necessary to take into account the toxicological aspects that dictate the importance of rational use of 4-aminoquinoline derivatives. This review analyzes literature on the development patterns of hydroxychloroquine retinopathy, basic principles of diagnosis and differentiation of this condition from other types of retinal pathology.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Betacoronavirus Tipo de estudio: Estudios diagnósticos / Estudio pronóstico Tópicos: Covid persistente Límite: Humanos Idioma: Ruso Revista: Vestn Oftalmol Año: 2020 Tipo del documento: Artículo País de afiliación: Oftalma2020136042265

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Betacoronavirus Tipo de estudio: Estudios diagnósticos / Estudio pronóstico Tópicos: Covid persistente Límite: Humanos Idioma: Ruso Revista: Vestn Oftalmol Año: 2020 Tipo del documento: Artículo País de afiliación: Oftalma2020136042265